Megan E. Vogel, Ph.D.

Megan E Vogel

Ph.D. in Pathobiology and Molecular Medicine, University of Cincinnati
B.S. in Chemistry, Ohio University

After completing her Ph.D. where she studied the early events in atherosclerosis, Megan switched into the field of diabetes and obesity, which she previously studied in her undergraduate studies. Megan is currently assisting in various projects in the Niswender laboratory, such as studying the human variants of GLP-1R as well as determining the mechanism(s) by which a GLP-1 agonist inhibits allergic airway inflammation (collaboration with Dr. Peebles).